Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues	$ 141,778	$ 513,244
Operating costs and expenses:
Research and development	3,017,263	4,184,820
Selling, general and administrative expenses	2,849,666	1,234,784
Total operating expenses	5,866,929	5,419,604
Loss from operations	(5,725,151)	(4,906,360)
Other income (expense):
Interest income	2	6
Interest expense	(1,644,829)	(209,538)
Interest expense, related, party	(572,347)	(1,076,478)
Change in fair value of derivative liability	15,282
Change in fair value of warrant liability	438,972
Forgiveness of PPP loan and accrued interest	408,242
Loss on debt modification	(2,385,204)
Total income (expense)	(3,739,882)	(1,286,010)
Loss before income taxes	(9,465,033)	(6,192,370)
Provision for income taxes
Net loss	$ (9,465,033)	$ (6,192,370)
Weighted average number of common shares outstanding – basic and diluted (in Shares)	5,300,084	4,298
Net loss per common share – basic and diluted (in Dollars per share)	$ (1.79)	$ (1,440.76)